BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1245783)

  • 1. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
    Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
    J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction.
    Niewiarowski S; Stewart GJ; Nath N; Sha AT; Lieberman GE
    Am J Physiol; 1975 Sep; 229(3):737-45. PubMed ID: 1211467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clot retraction facilitates clot lysis.
    Carroll RC; Gerrard JM; Gilliam JM
    Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
    De Clerck F; Borgers M; de Gaetano G; Vermylen J
    Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
    Jen CJ; McIntire LV
    Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting clot retraction and platelet aggregation. Clot retraction does not require an intact fibrinogen gamma chain C terminus.
    Rooney MM; Parise LV; Lord ST
    J Biol Chem; 1996 Apr; 271(15):8553-5. PubMed ID: 8621481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reptilase clot retraction test. (Its cofactors and relation to other platelet functions).
    Kubisz P; Suranova J
    Pathol Biol (Paris); 1975 Apr; 23(4):269-75. PubMed ID: 1097991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
    Gilliam JM; Berkus V; Taylor FB
    Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
    Tanoue K; Katagiri Y; Suzuki H
    Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction.
    Chao FC; Shepro D; Tullis JL; Belamarich FA; Curby WA
    J Cell Sci; 1976 May; 20(3):569-88. PubMed ID: 1270531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography.
    Katori N; Tanaka KA; Szlam F; Levy JH
    Anesth Analg; 2005 Jun; 100(6):1781-1785. PubMed ID: 15920213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan inhibits platelet-mediated clot retraction, increases platelet-derived growth factor release, and increases residence time and bioactivity of platelet-rich plasma in vivo.
    Deprés-Tremblay G; Chevrier A; Tran-Khanh N; Nelea M; Buschmann MD
    Biomed Mater; 2017 Nov; 13(1):015005. PubMed ID: 29125132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.